SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 37.14 |
| Enterprise Value ($M) | 39.08 |
| Book Value ($M) | -201.70 |
| Book Value / Share | -2.01 |
| Price / Book | -0.18 |
| NCAV ($M) | -221.59 |
| NCAV / Share | -2.20 |
| Price / NCAV | -0.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.16 |
| Current Ratio | 1.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 244.53 |
| Assets | 264.42 |
| Liabilities | 466.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 6.77 | -30.36 | |
| 13G/A | Vanguard Group Inc | 5.85 | 0.00 | |
| 13G/A | Primecap Management Co/ca/ | 9.87 | -31.51 | |
| 13G/A | BlackRock, Inc. | 2.40 | -66.56 | |
| 13G/A | Point72 Asset Management, L.P. | 1.70 | -73.83 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 615,813 | 1,738,872 | 35.41 | |
| 631,110 | 1,905,113 | 33.13 | |
| 1,119,511 | 3,639,743 | 30.76 | |
| 1,347,140 | 3,275,977 | 41.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EWTX – Edgewise Therapeutics, Inc. | EXEL – Exelixis, Inc. |
| FDMT – 4D Molecular Therapeutics, Inc. | GBIO – Generation Bio Co. |
| GERN – Geron Corporation |
Financial data and stock pages provided by
Fintel.io